At The DataLab we get many people contacting us every month asking us when OpenPrescribing will be available in their country. In this blog we are outlining OpenPrescribing.yourcountry where we give you the information that you can use locally to build a case for OpenPrescribing in your country and obtain funding to support development. We […]
Most people share their end of year roundup during late December when everyone is too full of cake to read. Now you’re back in the saddle, here’s our roundup of everything the DataLab threw out into the world over the previous 12 months! OpenPrescribing OpenPrescribing.net went from strength to strength, with over 135,000 unique users […]
We are seeking a researcher to fill this exciting role, working across our healthcare data projects, primarily OpenPrescribing, which helps users identify areas for improvement in primary care prescribing. However, you will also help us to develop our new interactive, data-driven tool on pathology tests requested by GPs, modelled on this. “OpenPathology.net” will help clinicians […]
Zuclopenthixol is an antipsychotic used for schizophrenia and other psychoses. In the UK, there are two injectable forms of zuclopenthixol: zuclopenthixol acetate : a short acting treatment used for acute episodes zuclopenthixol decanoate : a long acting treatment used for maintenance This week we launched a new measure to support a new type of alert […]
OpenPrescribing.net measure of seven day prescriptions for long-term conditions as a surrogate measure for Medicine Compliance Aids (MCAs). We measure seven day prescriptions for a basket of medicines; atorvastatin, simvastatin, levothyroxine, amlodipine and ramipril, commonly prescribed once daily for long term conditions.
At the DataLab we regularly collaborate on projects, both small and large, with users who get in touch. For development of this measure we would like to thank the NHS England Sustainable Unit and Centre for Sustainable Healthcare for their input on our work to support the NHS Long Term Plan. Another one of our […]